TGOD.TO stock C$0.17 intraday TSX Feb 2026 active: 19,704,275 volume shows trader interest

We see TGOD.TO stock trading at C$0.17 on the TSX this intraday session (04 Feb 2026). Volume has surged to 19,704,275 shares versus a 50-day average of 1,585,835, making TGOD.TO one of the most active names on the Canadian market right now. The intraday range is C$0.17–C$0.22 after opening at C$0.26, and year range sits at C$0.17–C$0.65. Traders are reacting to a mix of weak profitability metrics and high relative turnover in the healthcare cannabis segment.

TGOD.TO stock intraday price and volume

TGOD.TO stock is quoted at C$0.17 on the TSX during intraday trade. Volume reached 19,704,275, roughly 12.43x the average, which points to heavy trader interest. The stock opened at C$0.26, hit a day low of C$0.17 and a day high of C$0.22.

TGOD.TO stock fundamentals and valuation

The Green Organic Dutchman Holdings Ltd. reports trailing EPS -0.23 and a negative PE -0.74, reflecting recent losses. Key ratios: PB 0.45, EV C$35,113,000, current ratio 0.67, and debt/equity 0.33. Revenue per share is C$0.06 and book value per share is C$0.38, which supports the sub‑one price/book multiple versus many healthcare peers.

TGOD.TO stock technicals and trading context

Price sits below the 50-day average C$0.24 and 200-day average C$0.31, signaling downtrend pressure. Relative volume and the gap between the open and current price indicate intraday rebalancing and short-term trading flows. ATR is C$0.05, so recent intraday swings are material given the low absolute price.

TGOD.TO stock news and market catalysts

There is limited fresh company news; the most recent coverage in the public feed points to routine listing and historical press items. For context see aggregated headlines on MarketBeat and the company quote on Yahoo Finance. Volume-driven moves today appear driven by traders and speculative flow rather than a clear corporate catalyst.

Meyka AI rating and forecast for TGOD.TO stock

Meyka AI rates TGOD.TO with a score out of 100: 58.99 (Grade C+, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst signals. Meyka AI’s forecast model projects a monthly price of C$0.17, matching the current price and implying 0.00% near-term change. Enterprise value to sales sits at 1.63, and return metrics remain negative. Forecasts are model-based projections and not guarantees.

TGOD.TO stock outlook: targets and risk profile

We present three scenario targets to frame risk-reward for TGOD.TO stock. A conservative 12-month target of C$0.25 implies +47.06% upside. A bullish target at C$0.50 implies +194.12% upside. A downside stress target of C$0.10 implies -41.18%. These targets reflect operational recovery, market re-rating, or further execution risk; they are not guarantees.

Final Thoughts

TGOD.TO stock is trading as a high-volume, low-price speculative name on the TSX this intraday session. The stock’s C$0.17 price sits well below moving averages and is supported by a low price/book of 0.45 while profitability remains negative with EPS -0.23 and PE -0.74. Heavy volume of 19,704,275 shares suggests active position shifts by traders, not clear fundamentals-driven buying. Meyka AI’s model projects a monthly price of C$0.17, implying no immediate change from the current price. For risk-aware investors, the baseline 12-month target of C$0.25 (about +47.06%) requires revenue or margin improvements. We note sector pressure in healthcare cannabis and elevated volatility. Use tight risk controls, and consider liquidity and execution risk before trading TGOD.TO stock. Meyka AI is the AI-powered market analysis platform behind the grade and forecast; forecasts are model-based and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.